Atlas Trials

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Clinical trial NCT00313053 · TERMINATED

Trial details

NCT number
NCT00313053
Sponsor
Clare Twist
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Start date
2004-09-01
Primary completion
2008-04-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.